PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PRC Clinical

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PRC Clinical Announces Expansion of San Francisco Bay Area Offices - PRC Clinical today announced the expansion of its Bay Area offices to a larger facility in San Bruno, California. The company provides Phase I-IV contract services include project management, regional site monitoring, and site payment administration
PRC Clinical Announces Expansion of San Francisco Bay Area Offices

 

NewswireToday - /newswire/ - San Francisco, CA, United States, 2011/10/13 - PRC Clinical today announced the expansion of its Bay Area offices to a larger facility in San Bruno, California. The company provides Phase I-IV contract services include project management, regional site monitoring, and site payment administration.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“Our expanded building space will allow us to better serve our study Sponsors by making more efficient use of in-house staff as well as improvements to Essential Document housing and internal communication processes” said PRC Clinical Chief Executive Officer, Curtis Head. “We are pursuing our growth strategies of working with new Sponsors, increasing our presence with existing Sponsors and expanding into wider US geographies and anticipate a significant increase in our clinical management department” said Saira Singh, Senior Director, Business Development.
About PRC Clinical

PRC Clinical (Professional Research Consulting, Inc.), founded in 2002 and headquartered in San Francisco, is a privately held, niche Contract Research Organization (CRO) specializing in phase I-IV, clinical trial management services for virtual, small and mid-size pharmaceutical, biotechnology and medical device companies. PRC Clinical project teams are comprised of highly skilled and experienced clinical professionals, who are dedicated to a swift study start-up, meeting enrollment goals and on-time completion of the study within the budget. PRC Clinical has a broad range of therapeutic experience which includes cardiovascular, musculoskeletal, pulmonary, oncology, and neurology. PRC Clinical has significant experience in conducting registries and orphan drug trials.

PRC Clinical core services include trial management, regional monitoring, and Investigator payment services. Other consulting services include protocol development, clinical study report writing, medical monitoring, and clinical and regulatory auditing. Through established preferred partnerships, PRC Clinical also provides other clinical trial services, including data management, pharmacovigilance, and central and local laboratory services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PRC Clinical

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PRC Clinical Announces Expansion of San Francisco Bay Area Offices

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Saira Singh - PRCclinical.com 
877-519-6001 ssingh[.]prcclinical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PRC Clinical securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PRC Clinical / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)